Health specialists from China and the U.S. urge increased cooperation in the medical field
Health experts from China and the U.S. are advocating for enhanced medical collaboration.
TroibNews 
Over 500 scientists and experts from China and the United States convened in Beijing to tackle global health challenges and advocated for strengthened Sino-U.S. medical collaboration.
The Sino-American Forum of Academicians International Health Conference took place on November 16, 2024, hosted by the National Cancer Center of China.
Participants exchanged their latest insights and ideas across various topics, including trends in cancer research, medical innovation, cancer prevention, chronic disease management, cancer epidemiology, precision oncology, cancer genomics, and the utilization of artificial intelligence and big data in cancer studies.
Academician Chen Zhu, an honorary professor at the School of Medicine at Ruijin Hospital of Shanghai Jiaotong University, highlighted the fruitful and transformative nature of past collaborations between China and the U.S., noting that they have provided new solutions and hope to cancer patients around the globe.
Looking to the future, he emphasized the need for continued and deepened cooperation between the two nations, ranging from developments in precision medicine to innovative cancer prevention strategies.
Victor Joseph Dzau, co-chair of the conference and president of the United States National Academy of Medicine, remarked that the unprecedented global health challenges demand a stronger belief in the transformative power of science and scientific collaboration than ever before.
He noted that the assembly of scientists from both countries reflects a shared commitment to fulfilling academic missions, inspiring innovative ideas, and laying the groundwork for impactful actions and solutions aimed at shaping the global health landscape and saving millions of lives worldwide.
He Jie, an academician of the Chinese Academy of Sciences and director of the National Cancer Center of China, expressed his hope that the conference would promote deeper cooperation and exchanges in oncology between China and the U.S.
"I hope to further promote the provision of more precise, efficient, and safer healthcare services worldwide and reduce the global burden of cancer,” he stated.
He also conveyed his desire to establish an effective mechanism for cancer research collaboration with the U.S. on behalf of the National Cancer Center.
Mathilde Moreau for TROIB News
The Sino-American Forum of Academicians International Health Conference took place on November 16, 2024, hosted by the National Cancer Center of China.
Participants exchanged their latest insights and ideas across various topics, including trends in cancer research, medical innovation, cancer prevention, chronic disease management, cancer epidemiology, precision oncology, cancer genomics, and the utilization of artificial intelligence and big data in cancer studies.
Academician Chen Zhu, an honorary professor at the School of Medicine at Ruijin Hospital of Shanghai Jiaotong University, highlighted the fruitful and transformative nature of past collaborations between China and the U.S., noting that they have provided new solutions and hope to cancer patients around the globe.
Looking to the future, he emphasized the need for continued and deepened cooperation between the two nations, ranging from developments in precision medicine to innovative cancer prevention strategies.
Victor Joseph Dzau, co-chair of the conference and president of the United States National Academy of Medicine, remarked that the unprecedented global health challenges demand a stronger belief in the transformative power of science and scientific collaboration than ever before.
He noted that the assembly of scientists from both countries reflects a shared commitment to fulfilling academic missions, inspiring innovative ideas, and laying the groundwork for impactful actions and solutions aimed at shaping the global health landscape and saving millions of lives worldwide.
He Jie, an academician of the Chinese Academy of Sciences and director of the National Cancer Center of China, expressed his hope that the conference would promote deeper cooperation and exchanges in oncology between China and the U.S.
"I hope to further promote the provision of more precise, efficient, and safer healthcare services worldwide and reduce the global burden of cancer,” he stated.
He also conveyed his desire to establish an effective mechanism for cancer research collaboration with the U.S. on behalf of the National Cancer Center.
Mathilde Moreau for TROIB News
